Trial site

Mayo Clinic Comprehensive Cancer Center

Phoenix, Arizona 85054, United StatesNot linked to an institution yet

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions: Colorectal cancer4 trials
Lung cancer2 trials
Pancreatic cancer2 trials
Triple-negative breast cancer2 trials
Bladder cancer1 trial
Endometrial cancer1 trial
Kidney cancer1 trial
Liver and biliary tract cancer1 trial
Metastatic breast cancer1 trial
Neuroblastoma1 trial
Ovarian cancer1 trial
Sarcoma1 trial
Phase: Phase 1/24 trials
Phase 11 trial
Status: Recruiting3 trials
Active, not recruiting1 trial
Not yet recruiting1 trial
Lead sponsor: Alentis Therapeutics AG1 trial
Day One Biopharmaceuticals, Inc.1 trial
Elicio Therapeutics1 trial
Kura Oncology, Inc.1 trial
QuantumLeap Healthcare Collaborative1 trial

Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
NCT07169734· Phase 1/2· Alentis Therapeutics AG· Source
Contact: Principal Investigator
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06026410· Phase 1· Kura Oncology, Inc.· Source
Active, not recruiting
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
NCT05726864· Phase 1/2· Elicio Therapeutics· Source
Recruiting
PRE-ISPY Phase I/II Oncology Platform Program
NCT05868226· Phase 1/2· QuantumLeap Healthcare Collaborative· Source
Contact: Clinical Trials Referral Office
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
NCT05377996· Phase 1/2· Day One Biopharmaceuticals, Inc.· Source
Contact: Felipe Batalini, MD

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 12 Nov 2026